{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:42:09Z","timestamp":1789944129439,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Lundbeck Foundation","award":["R223-2015-4222"],"award-info":[{"award-number":["R223-2015-4222"]}]},{"name":"The Lundbeck Foundation","award":["R248-2016-25"],"award-info":[{"award-number":["R248-2016-25"]}]},{"name":"The Lundbeck Foundation","award":["R248-2016-2518"],"award-info":[{"award-number":["R248-2016-2518"]}]},{"DOI":"10.13039\/100000864","name":"The Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"crossref","award":["13750"],"award-info":[{"award-number":["13750"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216764","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T13:33:54Z","timestamp":1570800834000},"page":"e0216764","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Stabilization of \u03b1-synuclein oligomers using formaldehyde"],"prefix":"10.1371","volume":"14","author":[{"given":"Harm","family":"Ruesink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-3185","authenticated-orcid":true,"given":"Lasse","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Betzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul Henning","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"issue":"7","key":"pone.0216764.ref001","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"M. Goedert","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"pone.0216764.ref002","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"D. Eliezer","year":"2001","journal-title":"J Mol Biol"},{"issue":"2","key":"pone.0216764.ref003","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"A. Iwai","year":"1995","journal-title":"Neuron"},{"issue":"5999","key":"pone.0216764.ref004","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"J. Burre","year":"2010","journal-title":"Science"},{"issue":"9440","key":"pone.0216764.ref005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"M.C. Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"pone.0216764.ref006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"R. Kruger","year":"1998","journal-title":"Nat Genet"},{"issue":"5321","key":"pone.0216764.ref007","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"M.H. Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"2","key":"pone.0216764.ref008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"J.J. Zarranz","year":"2004","journal-title":"Ann Neurol"},{"issue":"6645","key":"pone.0216764.ref009","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"M.G. Spillantini","year":"1997","journal-title":"Nature"},{"issue":"Pt 4","key":"pone.0216764.ref010","first-page":"1093","article-title":"Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"K.E. Paleologou","year":"2009","journal-title":"Brain"},{"issue":"6","key":"pone.0216764.ref011","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/brain\/awv040","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain","volume":"138","author":"R.F. Roberts","year":"2015","journal-title":"Brain"},{"issue":"3","key":"pone.0216764.ref012","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","article-title":"Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation","volume":"137","author":"H. Sekiya","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"10","key":"pone.0216764.ref013","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"B. Winner","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"pone.0216764.ref014","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar \u03b1-synuclein variants with impaired \u03b2-structure increase neurotoxicity in Parkinson's disease models","volume":"28","author":"D.P. Karpinar","year":"2009","journal-title":"The EMBO Journal"},{"issue":"1","key":"pone.0216764.ref015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"M.H.R. Ludtmann","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0216764.ref016","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","article-title":"Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology","volume":"111","author":"K.M. Danzer","year":"2009","journal-title":"J Neurochem"},{"issue":"34","key":"pone.0216764.ref017","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"K.M. Danzer","year":"2007","journal-title":"J Neurosci"},{"issue":"10","key":"pone.0216764.ref018","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","article-title":"Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway","volume":"19","author":"R. Cappai","year":"2005","journal-title":"Faseb j"},{"issue":"5","key":"pone.0216764.ref019","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"H.A. Lashuel","year":"2002","journal-title":"J Mol Biol"},{"issue":"51","key":"pone.0216764.ref020","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1021\/bi4009193","article-title":"Characterizing the Dynamics of \u03b1-Synuclein Oligomers Using Hydrogen\/Deuterium Exchange Monitored by Mass Spectrometry","volume":"52","author":"S. Mysling","year":"2013","journal-title":"Biochemistry"},{"issue":"2","key":"pone.0216764.ref021","doi-asserted-by":"crossref","first-page":"e0116473","DOI":"10.1371\/journal.pone.0116473","article-title":"Identification of synaptosomal proteins binding to monomeric and oligomeric alpha-synuclein","volume":"10","author":"C. Betzer","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pone.0216764.ref022","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744617","article-title":"Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation","volume":"19","author":"C. Betzer","year":"2018","journal-title":"EMBO Rep"},{"issue":"4","key":"pone.0216764.ref023","doi-asserted-by":"crossref","first-page":"e0196056","DOI":"10.1371\/journal.pone.0196056","article-title":"ELISA method to detect \u03b1-synuclein oligomers in cell and animal models","volume":"13","author":"L.B. Lassen","year":"2018","journal-title":"PLoS ONE"},{"issue":"12","key":"pone.0216764.ref024","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1007\/s11064-017-2382-x","article-title":"The Oligomer Hypothesis in \u03b1-Synucleinopathy","volume":"42","author":"K. Ono","year":"2017","journal-title":"Neurochemical Research"},{"issue":"3","key":"pone.0216764.ref025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease","volume":"20","author":"O.M. El-Agnaf","year":"2006","journal-title":"Faseb j"},{"issue":"4","key":"pone.0216764.ref026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3988\/jcn.2011.7.4.215","article-title":"Elevated levels of \u03b1-synuclein oligomer in the cerebrospinal fluid of drug-na\u00efve patients with Parkinson's disease","volume":"7","author":"M.J. Park","year":"2011","journal-title":"Journal of clinical neurology (Seoul, Korea)"},{"issue":"20","key":"pone.0216764.ref027","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"T. Tokuda","year":"2010","journal-title":"Neurology"},{"key":"pone.0216764.ref028","first-page":"79","volume-title":"Chapter Three\u2014Structural Characteristics of \u03b1-Synuclein Oligomers, in International Review of Cell and Molecular Biology","author":"N. Cremades","year":"2017"},{"key":"pone.0216764.ref029","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"L. Bousset","year":"2013","journal-title":"Nat Commun"},{"issue":"28","key":"pone.0216764.ref030","doi-asserted-by":"crossref","first-page":"21500","DOI":"10.1074\/jbc.M000099200","article-title":"Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments","volume":"275","author":"P.H. Jensen","year":"2000","journal-title":"J Biol Chem"},{"issue":"13","key":"pone.0216764.ref031","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"E. Lindersson","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0216764.ref032","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pep.2005.02.014","article-title":"A new method for purification of recombinant human alpha-synuclein in Escherichia coli","volume":"42","author":"C. Huang","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"3","key":"pone.0216764.ref033","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsb.2018.05.008","article-title":"Know your detergents: A case study on detergent background in negative stain electron microscopy","volume":"203","author":"T. Gewering","year":"2018","journal-title":"J Struct Biol"},{"issue":"8","key":"pone.0216764.ref034","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nmeth.2533","article-title":"Engineered nanostructured \u03b2-sheet peptides protect membrane proteins","volume":"10","author":"H. Tao","year":"2013","journal-title":"Nature methods"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:54:09Z","timestamp":1588967649000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216764"}},"subtitle":[],"editor":[{"given":"Mark R.","family":"Cookson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216764","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/623538","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]}}}